Harvard Bioscience, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-865.0K | $-4.3M | $-19.0M | $2.4M | $-1.8M | $2.4M | $3.8M | $19.0M |
| Depreciation & Amortization | — | — | — | — | — | $4.2M | $4.3M | $3.9M |
| Depreciation | $1.3M | $1.5M | $1.7M | $1.3M | $1.3M | $1.3M | $1.3M | $1.2M |
| Amortization | $1.6M | $2.7M | $2.8M | $2.6M | $2.6M | $2.8M | $2.7M | $2.4M |
| Stock-Based Compensation | $3.5M | $3.5M | $2.8M | $2.2M | $2.7M | $3.3M | $2.9M | $2.8M |
| Net Cash from Operating Activities | $1.1M | $5.4M | $705.0K | $4.4M | $4.1M | $8.1M | $6.6M | $12.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $890.0K | — | — | — | — | — | — | — |
| Business Acquisitions | $0 | $0 | $4.5M | $12.7M | $0 | $2.9M | $5.5M | $7.1M |
| Net Cash from Investing Activities | $-917.0K | $-62.0K | $-7.5M | $-13.5M | $171.0K | $-4.7M | $-7.2M | $-8.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-1.8M | $-4.9M | $-540.0K | $-1.2M | $68.0K | $-1.1M | $-1.1M | $-31.0K |
| Net Change in Cash | $137.0K | $-1.1M | $-7.4M | $-11.6M | $5.1M | $2.8M | $-1.8M | $3.1M |
| Free Cash Flow | $167.0K | — | — | — | — | — | — | — |